Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1982 1
1984 2
1985 1
1986 1
1988 1
1991 1
1992 1
1994 1
1995 2
1997 3
1998 1
1999 2
2000 1
2001 2
2002 6
2003 4
2004 2
2005 3
2006 4
2007 3
2008 5
2009 1
2010 2
2011 6
2012 7
2013 4
2014 3
2016 2
2017 4
2018 1
2019 5
2020 5
2021 4
2022 3
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

95 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Pseudohypoaldosteronism Type 1, Autosomal Recessive"
Page 1
Pseudohypoaldosteronism.
Riepe FG. Riepe FG. Endocr Dev. 2013;24:86-95. doi: 10.1159/000342508. Epub 2013 Feb 1. Endocr Dev. 2013. PMID: 23392097 Review.
Pseudohypoaldosteronism (PHA) is a rare syndrome of mineralocorticoid resistance. ...
Pseudohypoaldosteronism (PHA) is a rare syndrome of mineralocorticoid resistance. ...
Phenotypic diversity and correlation with the genotypes of pseudohypoaldosteronism type 1.
Gopal-Kothandapani JS, Doshi AB, Smith K, Christian M, Mushtaq T, Banerjee I, Padidela R, Ramakrishnan R, Owen C, Cheetham T, Dimitri P. Gopal-Kothandapani JS, et al. J Pediatr Endocrinol Metab. 2019 Sep 25;32(9):959-967. doi: 10.1515/jpem-2018-0538. J Pediatr Endocrinol Metab. 2019. PMID: 31301676
Background Type I pseudohypoaldosteronism (PHA1) is a rare condition characterised by profound salt wasting, hyperkalaemia and metabolic acidosis due to renal tubular resistance to aldosterone (PHA1a) or defective sodium epithelial channels (PHA1b or systemic PHA). ...
Background Type I pseudohypoaldosteronism (PHA1) is a rare condition characterised by profound salt wasting, hyperkalaemia and metabo …
Modelling mucociliary clearance.
Smith DJ, Gaffney EA, Blake JR. Smith DJ, et al. Respir Physiol Neurobiol. 2008 Nov 30;163(1-3):178-88. doi: 10.1016/j.resp.2008.03.006. Epub 2008 Mar 20. Respir Physiol Neurobiol. 2008. PMID: 18439882 Review.
Modelling results are related to clinical findings, in particular the increased MCC observed in patients with pseudohypoaldosteronism. Recent important advances by several groups in modelling the fluid-structure interaction by which the cilia movement and fluid transport e …
Modelling results are related to clinical findings, in particular the increased MCC observed in patients with pseudohypoaldosteronism …
Clinical and Molecular Perspectives of Monogenic Hypertension.
Levanovich PE, Diaczok A, Rossi NF. Levanovich PE, et al. Curr Hypertens Rev. 2020;16(2):91-107. doi: 10.2174/1573402115666190409115330. Curr Hypertens Rev. 2020. PMID: 30963979 Free PMC article. Review.
Geller syndrome is due to a point mutation in the hormone responsive element of the promotor for the mineralocorticoid receptor, rendering the receptor susceptible to activation by progesterone, leading to hypertension during pregnancy. Pseudohypoaldosteronism type II (PHA …
Geller syndrome is due to a point mutation in the hormone responsive element of the promotor for the mineralocorticoid receptor, rendering t …
Clinical characteristics and treatment requirements of children with autosomal recessive pseudohypoaldosteronism.
Bandhakavi M, Wanaguru A, Ayuk L, Kirk JM, Barrett TG, Kershaw M, Högler W, Shaw NJ. Bandhakavi M, et al. Eur J Endocrinol. 2021 May;184(5):K15-K20. doi: 10.1530/EJE-20-0152. Eur J Endocrinol. 2021. PMID: 33690157
INTRODUCTION: Autosomal recessive forms of pseudohypoaldosteronism are caused by genetic defects in the epithelial sodium channel. ...
INTRODUCTION: Autosomal recessive forms of pseudohypoaldosteronism are caused by genetic defects in the epithelial sodium channel. .. …
Salt-Losing Syndrome in a Girl with Type I and II Pseudohypoaldosteronism.
Szmigielska A. Szmigielska A. Am J Case Rep. 2022 Oct 28;23:e937536. doi: 10.12659/AJCR.937536. Am J Case Rep. 2022. PMID: 36303414 Free PMC article.
BACKGROUND Pseudohypoaldosteronism (PHA) is characterized by renal tubular resistance to aldosterone and leads to hyponatremia, hyperkalemia, and metabolic acidosis. ...Increased salt concentration in sweat and saliva may suggest pseudohypoaldosteronism....
BACKGROUND Pseudohypoaldosteronism (PHA) is characterized by renal tubular resistance to aldosterone and leads to hyponatremia, hyper …
KLHL3-dependent WNK4 degradation affected by potassium through the neddylation and autophagy pathway.
Ying S, Guo Q, Zhang C. Ying S, et al. BMC Nephrol. 2023 Jul 22;24(1):217. doi: 10.1186/s12882-023-03257-4. BMC Nephrol. 2023. PMID: 37481568 Free PMC article.
Impaired WNK4 ubiquitination plays a key role in Familial hyperkalemic hypertension (FHHt, also called pseudohypoaldosteronism type II) which results from overaction of thiazide-sensitive sodium chloride cotransport (NCC). ...
Impaired WNK4 ubiquitination plays a key role in Familial hyperkalemic hypertension (FHHt, also called pseudohypoaldosteronism type I …
Difficulties in the diagnosis and management of eight infants with secondary pseudohypoaldosteronism.
Günay F, Şıklar Z, Berberoğlu M. Günay F, et al. Turk J Pediatr. 2022;64(3):490-499. doi: 10.24953/turkjped.2021.1443. Turk J Pediatr. 2022. PMID: 35899562 Free article.
BACKGROUND: Type 1 pseudohypoaldosteronism (PHA1) is a rare condition characterized by the resistance of the kidney to the effect of aldosterone. ...
BACKGROUND: Type 1 pseudohypoaldosteronism (PHA1) is a rare condition characterized by the resistance of the kidney to the effect of …
95 results